Abstract
The molecular chaperone Hsp90 is an essential member of the cellular proteostasis system. It plays an important role in the stabilisation and activation of a large number of client proteins and is involved in fatal disease processes, e.g. Alzheimer disease, cancer and cystic fibrosis. This makes Hsp90 a crucial protein to study. Mechanistic studies require large amounts of protein but the production and purification of recombinant human Hsp90 in Escherichia coli is challenging and laborious. Here we identified conditions that influence Hsp90 production, and optimised a fast and efficient purification protocol. We found that the nutrient value of the culturing medium and the length of induction had significant effect on Hsp90 production in Escherichia coli. Our fast, single-day purification protocol resulted in a stable, well-folded and pure sample that was resistant to degradation in a reproducible manner. We anticipate that our results provide a useful tool to produce higher amount of pure, well-folded and stable recombinant human Hsp90β in Escherichia coli in an efficient way.
MeSH terms
-
Bacteriological Techniques
-
Circular Dichroism
-
Culture Media / chemistry
-
Escherichia coli / genetics*
-
Escherichia coli / metabolism*
-
HSP90 Heat-Shock Proteins / biosynthesis*
-
HSP90 Heat-Shock Proteins / genetics*
-
HSP90 Heat-Shock Proteins / isolation & purification
-
Humans
-
Molecular Weight
-
Protein Folding
-
Protein Stability
-
Proteolysis
-
Recombinant Proteins / biosynthesis
-
Recombinant Proteins / genetics
-
Recombinant Proteins / isolation & purification
Substances
-
Culture Media
-
HSP90 Heat-Shock Proteins
-
HSP90AB1 protein, human
-
Recombinant Proteins
Grants and funding
This work was supported by the Internationale Stichting Alzheimer Onderzoek (ISAO), grant No. 14542, (
https://www.alzheimer-nederland.nl), FP7 ITN-IDP "ManiFold", grant No. 317371, Marie Curie Actions, Europeans Commission, (
https://ec.europa.eu/research/mariecurieactions/), FP7 ITN "WntsApp", grant No. 608180, Marie Curie Actions, Europeans Commission, (
https://ec.europa.eu/research/mariecurieactions/) and The Netherlands Organisation for Health Research and Development (ZonMW), Grant No. 91215084 (
https://www.zonmw.nl/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.